References
1. Thijssen M, Lemey P, Amini-Bavil-Olyaee S, Dellicour S, Alavian SM, Tacke F, et al. Mass migration to Europe: an opportunity for elimination of hepatitis B virus? The Lancet Gastroenterology & Hepatology. 2019;4(4):315-23.
2. Nimer NA. A review on emerging and reemerging of infectious diseases in Jordan: the aftermath of the Syrian crises. Canadian Journal of Infectious Diseases and Medical Microbiology. 2018;2018.
3. Assi R, Özger-İlhan S, İlhan M. Health needs and access to health care: The case of Syrian refugees in Turkey. Public Health. 2019;172:146-52.
4. Pottie K, Mayhew AD, Morton RL, Greenaway C, Akl EA, Rahman P, et al. Prevention and assessment of infectious diseases among children and adult migrants arriving to the European Union/European Economic Association: A protocol for a suite of systematic reviews for public health and health systems. BMJ open. 2017;7(9):e014608.
5. García-Tardón N, Gresnigt TM, Fofanah AB, Grobusch MP. Hepatitis B and C in tonkolili province, sierra leone. The Lancet. 2017;390(10101):1485.
6. Organization WH. Global hepatitis report 2017: World Health Organization; 2017.
7. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Journal of viral hepatitis. 2004;11(2):97-107.
8. Directorate general of migration management of Turkish Ministry of interior temporary protection statistics. 2021 [cited 2021]. Available from: https://en.goc.gov.tr/temporary-protection27.
9. Tozun N, Ozdogan O, Cakaloglu Y, Idilman R, Karasu Z, Akarca U, et al. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clinical Microbiology and Infection. 2015;21(11):1020-6.
10. Turkey viral hepatitis prevention and control program. 2018-2023 2018 [2021]. Available from: https://www.globalhep.org.
11. Köse Ş, Ödemiş I, Çelik D, Tatar G, Akbulut I, Çiftdoğan DY. Hepatitis A, B, C and HIV seroprevalence among Syrian refugee children admitted to outpatient clinics. Le infezioni in medicina. 2017;25(4):339-43.
12. Bashour H, Muhjazi G. Hepatitis B and C in the Syrian Arab Republic: a review. EMHJ-Eastern Mediterranean Health Journal. 2016;22(4):267-73.
13. Antaki N, Haffar S, Deeb SA, Assaad F, Abou Harb R, Zeibane N, et al. High prevalence of HBV genotype D in Syria and the clinical characteristics of hepatitis B e antigen-negative chronic hepatitis B. Epidemiology & Infection. 2010;138(1):40-4.
14. AŞGIN N, SATILMIŞ Ş. An Evaluation of Hepatitis B Virus and Hepatitis C Virus Frequency and the Anti-hepatitis B Surface Seropositivity of Syrian Refugees in the Karabük Province. Viral Hepatitis Journal. 2019;25(3):84-7.
15. ÖZKAYA E, KİRİŞCİ Ö, ÇALIŞKAN A, TÜMER S, ŞENOL H. Son İki Yılda Kahramanmaraş Necip Fazıl Şehir Hastanesine Başvuran Suriye Kökenli ve Suriye Kökenli Olmayan Hastalara Ait Serum Örneklerindeki HBsAg, Anti-HBs ve Anti-HCV Pozitifliklerinin Değerlendirilmesi. FLORA. 2015;20(3):128-32.
16. Tümtürk A, Yeşil B. Hepatitis B, Hepatitis C and HIV seroprevalence among Syrian refugees: A cross-sectional study from a tertiary referral center in Turkey. Hospital. 2018(58/29620911).
17. Syrian Arab Republic: WHO and UNICEF estimates of immunization coverage: 2017 revision. WHO 2018 [2021]. Available from: https://www.who.int/immunization/monitoring_ surveillance/data/syr.pdf.
18. UNICEF in Turkey worked closely with the Ministry of Health (MoH) on vaccination campaigns for all refugee and migrant children under five in 2017. 2021 [cited 2021]. Available from: https://www.unicef.org/turkey/en/immunization.
19. Ergönül Ö, Tülek N, Kayı I, Irmak H, Erdem O, Dara M. Profiling infectious diseases in Turkey after the influx of 3.5 million Syrian refugees. Clinical Microbiology and Infection. 2020;26(3):307-12.
20. Ministry of interior Temporary Protection in Law on Foreigners and International Protection. 2021 2021 [cited 2021]. Available from: https://en.goc.gov.tr/temporary-protection-in-law-on-foreigners-and-international protection.
21. Lavanchy D. The global burden of hepatitis C. Liver international. 2009;29:74-81.
22. Chemaitelly H, Chaabna K, Abu-Raddad LJ. The epidemiology of hepatitis C virus in the Fertile Crescent: systematic review and meta-analysis. PloS one. 2015;10(8):e0135281.
23. Gökengin D, Doroudi F, Tohme J, Collins B, Madani N. HIV/AIDS: trends in the Middle East and North Africa region. International Journal of Infectious Diseases. 2016;44:66-73.
24. Inci A, Sarici IS, Caliskan G, Kalayci MU. Investigation of frequency of Hbsag, anti Hbs, anti Hcv and anti Hiv in refugee patients from syria who admit to a training and research hospital department of surgery. Acta Medica Mediterranea. 2017;33(1):59-63.